Cozaar (losartan potassium) tablets are indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to black patients. For more information, contact Merck & Co. Inc., 866-448-7590, www.cozaar.com.
Related Results
CozaarCozaar Sales.FDA gives Cozaar new indicationStudy shows Cozaar has marked benefitsTeva Announces Tentative Approval for Generic Cozaar Tablets
COPYRIGHT 2003 International Medical News Group
COPYRIGHT 2008 Gale, Cengage Learning